Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT07072793
Eligibility Criteria:
Inclusion Criteria:
* \>1 non-diagnostic2 outpatient medical claim in the MarketScan Commercial or Medicare Database with the International Classification of Diseases, 10th Revision (ICD-10) diagnosis code for COVID-19 (U071) between December 16, 2021 (5 days prior to the date of emergency use authorization of NMV/r) and December 1, 2022 (30 days prior to the end of available HPM data); the date of the earliest qualifying claim is the index date.
* Primary beneficiary on their insurance policy (i.e., eligible for inclusion in the MarketScan HPM Database)
* \>6 months of continuous enrollment with medical and pharmacy benefits in the MarketScan Commercial or Medicare Database before the index date (baseline period)
* \>30 days of continuous enrollment with medical and pharmacy benefits in the MarketScan Commercial or Medicare Database after and including the index date (minimum follow-up period)
* Treated cohort ONLY: ≥1 claim for Paxlovid within 5 days of index (index date and next 4 days)
Exclusion Criteria:
* Evidence of death on the index date or the following day
* Any inpatient admission on the index date or the following day
* ≥1 inpatient claim with a COVID-19 diagnosis in any position on the claim during the 30 days before the index date
* \>1 non-diagnostic claim with a diagnosis code for stage 4 or stage 5 chronic kidney disease, end stage renal disease, or a procedure code for dialysis, during the baseline period or on the index date
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07072793
Study Brief:
Protocol Section:
NCT07072793